Kalytera Therapeutics Inc Share Price Toronto S.E.
Equities
CA48349P1036
Biotechnology & Medical Research
Sales 2019 | - | Sales 2020 | - | Capitalization | 13.65M 18.67M 1.14B |
---|---|---|---|---|---|
Net income 2019 | -21M -28.72M -1.75B | Net income 2020 | 4M 5.47M 334M | EV / Sales 2019 | - |
Net Debt 2019 | 704K 963K 58.79M | Net Debt 2020 | 920K 1.26M 76.83M | EV / Sales 2020 | - |
P/E ratio 2019 |
-0.9
x | P/E ratio 2020 |
3.17
x | Employees | - |
Yield 2019 * |
-
| Yield 2020 |
-
| Free-Float | 99.74% |
1st Jan change | Capi. | |
---|---|---|
+25.83% | 47.96B | |
+0.69% | 42.45B | |
+44.25% | 41.47B | |
+30.52% | 31.6B | |
+22.30% | 28.63B | |
-6.35% | 28.03B | |
+49.25% | 14.56B | |
+49.18% | 14.14B | |
+3.45% | 12.58B |